Emergent BioSolutions Inc.

NYSE: EBS
Share price (10/21/25): $9.45
Market cap (10/21/25): $504 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement

Prospectus supplement

Updated info for already-effective prospectus

Additional exhibits for registration

Ownership Filter

Lindahl Richard S

Glessner Coleen

Glessner Coleen

News Filter

Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) From the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Reports Second Quarter 2025 Financial Results

Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Stipulation and Agreement of Settlement

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Scanned paper annual report submission